The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
Open Access
- 19 March 2024
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (9) , 1780-1816
Abstract
Bipolar disorder (BD) is a severe and multifactorial disease, with onset usually in young adulthood, which follows a progressive course throughout life. Replicated epidemiological studies have suggested inflammatory mechanisms and neuroimmune risk factors as primary contributors to the onset and development of BD. While not all patients display overt markers of inflammation, significant evidence suggests that aberrant immune signaling contributes to all stages of the disease and seems to be mood phase dependent, likely explaining the heterogeneity of findings observed in this population. As the brain's immune cells, microglia orchestrate the brain's immune response and play a critical role in maintaining the brain's health across the lifespan. Microglia are also highly sensitive to environmental changes and respond to physiological and pathological events by adapting their functions, structure, and molecular expression. Recently, it has been highlighted that instead of a single population of cells, microglia comprise a heterogeneous community with specialized states adjusted according to the local molecular cues and intercellular interactions. Early evidence has highlighted the contribution of microglia to BD neuropathology, notably for severe outcomes, such as suicidality. However, the roles and diversity of microglial states in this disease are still largely undermined. This review brings an updated overview of current literature on the contribution of neuroimmune risk factors for the onset and progression of BD, the most prominent neuroimmune abnormalities (including biomarker, neuroimaging, ex vivo studies) and the most recent findings of microglial involvement in BD neuropathology. Combining these different shreds of evidence, we aim to propose a unifying hypothesis for BD pathophysiology centered on neuroimmune abnormalities and microglia. Also, we highlight the urgent need to apply novel multi‐system biology approaches to characterize the diversity of microglial states and functions involved in this enigmatic disorder, which can open bright perspectives for novel biomarkers and therapeutic discoveries. imageKeywords
Funding Information
- University of Victoria
This publication has 280 references indexed in Scilit:
- Altered functional activity in bipolar disorder: A comprehensive review from a large‐scale network perspectiveBrain and Behavior, 2020
- Long-term Risk of Neuropsychiatric Disease After Exposure to Infection In UteroJAMA Psychiatry, 2019
- Whither Research Domain Criteria (RDoC)?JAMA Psychiatry, 2015
- State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive DisorderJAMA Psychiatry, 2015
- Gestational Influenza and Bipolar Disorder in Adult OffspringJAMA Psychiatry, 2013
- Neuron‐oligodendrocyte myelination co‐culture derived from embryonic rat spinal cord and cerebral cortexBrain and Behavior, 2012
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- Evidence for synaptic stripping by cortical microgliaGlia, 2006
- Reduced Muscarinic Type 2 Receptor Binding in Subjects With Bipolar DisorderArchives of General Psychiatry, 2006
- TGF‐β‐treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF‐c‐Met pathwayEuropean Journal of Immunology, 2005